Characterization of Δnp73 expression and regulation in gastric and esophageal tumors

Oncogene

Volumn 29, Issue 43, 2010, Pages 5861-5868

  Vilgelm, A E ^a,b   Hong, S M ^c   Washington, M K ^a   Wei, J ^a   Chen, H ^d   El Rifai, W ^a   Zaika, A ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

esophageal tumor; gastric tumor; p73

Indexed keywords

MESSENGER RNA; PROTEIN P73;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BINDING SITE; CANCER SURVIVAL; CARCINOGENICITY; CELL GROWTH; CHROMATIN IMMUNOPRECIPITATION; EPITHELIUM CELL; ESOPHAGUS TUMOR; GENE EXPRESSION; HUMAN; LOWER ESOPHAGUS SPHINCTER; MUCOSA CELL; MUTAGENESIS; PRIORITY JOURNAL; PROMOTER REGION; STOMACH TUMOR; TRANSCRIPTION REGULATION; UPREGULATION;

BASE SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; CONSERVED SEQUENCE; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 78049338121     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.319     Document Type: Article

References (21)

1. Buhlmann S, Putzer BM. (2008). DNp73 a matter of cancer: mechanisms and clinical implications. Biochim Biophys Acta 1785: 207-216.
2. Cam H, Griesmann H, Beitzinger M, Hofmann L, Beinoraviciute-Kellner R, Sauer M et al. (2006). p53 family members in myogenic differentiation and rhabdomyosarcoma development. Cancer Cell 10: 281-293.
3. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A et al. (2005). MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942.
4. Casciano I, Mazzocco K, Boni L, Pagnan G, Banelli B, Allemanni G et al. (2002). Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ 9: 246-251.
5. Chen WY, Baylin SB. (2005). Inactivation of tumor suppressor genes: choice between genetic and epigenetic routes. Cell Cycle 4: 10-12.
6. Grob TJ, Novak U, Maisse C, Barcaroli D, Luthi AU, Pirnia F et al. (2001). Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 8: 1213-1223.
7. Kanai Y, Ushijima S, Ochiai A, Eguchi K, Hui A, Hirohashi S. (1998). DNA hypermethylation at the D17S5 locus is associated with gastric carcinogenesis. Cancer Lett 122: 135-141.
8. Kartasheva NN, Contente A, Lenz-Stoppler C, Roth J, Dobbelstein M. (2002). p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop. Oncogene 21: 4715-4727.
9. Lin KW, Nam SY, Toh WH, Dulloo I, Sabapathy K. (2004). Multiple stress signals induce p73beta accumulation. Neoplasia 6: 546-557.
10. Loots GG, Ovcharenko I. (2004). rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res 32: W217-W221.
11. Melino G, Lu X, Gasco M, Crook T, Knight RA. (2003). Functional regulation of p73 and p63: development and cancer. Trends Biochem Sci 28: 663-670.
12. Nakagawa T, Takahashi M, Ozaki T, Watanabe Ki K, Todo S, Mizuguchi H et al. (2002). Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. Mol Cell Biol 22: 2575-2585.
13. Petrenko O, Zaika A, Moll UM. (2003). deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo. Mol Cell Biol 23: 5540-5555.
14. Stiewe T, Tuve S, Peter M, Tannapfel A, Elmaagacli AH, Putzer BM. (2004). Quantitative TP73 transcript analysis in hepatocellular carcinomas. Clin Cancer Res 10: 626-633.
15. Tannapfel A, John K, Mise N, Schmidt A, Buhlmann S, Ibrahim SM et al. (2008). Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73. Carcinogenesis 29: 211-218.
16. Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC et al. (2008). TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 22: 2677-2691.
17. Vilgelm A, El-Rifai W, Zaika A. (2008a). Therapeutic prospects for p73 and p63: rising from the shadow of p53.
18. Drug Resist Updat 11: 152-163. Vilgelm A, Wei JX, Piazuelo MB, Washington MK, Prassolov V, El-Rifai W et al. (2008b). DeltaNp73alpha regulates MDR1 expression by inhibiting p53 function. Oncogene 27: 2170-2176.
19. Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK et al. (1995). p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1: 570-577.
20. Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen OW et al. (2002). Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 94: 1494-1503.
21. Zaika AI, El-Rifai W. (2006). The role of p53 protein family in gastrointestinal malignancies. Cell Death Differ 13: 935-940.